| Language and cultural differences are just two of the pressures
facing the pharmaceutical, healthcare and medical device
industries in the new global economy, and they are issues that
companies cannot afford to fail to address adequately. These
two issues alone can affect the successful international rollout
of healthcare products. To obtain international compliance,
packaging and supporting documentation have to be translated
and culturally customised accurately across a range of languages.
Today, the global pharmaceutical industry is worth over $550 billion
(1). By 2020, PricewaterhouseCoopers estimates that the global
pharmaceutical market will be worth $1.3 trillion (2). This increase
will be due to rising global demand for medicines as the population
increases, ages and faces more disease. In order to take advantage of
future growth opportunities, pharmaceutical companies must ensure
that they successfully penetrate global markets by culturally
customising all collateral related to their product. GLOBAL CHALLENGES FACING
THE PHARMACEUTICAL INDUSTRY
The challenges for pharmaceutical companies in a global,
continuously expanding market are intense. There is pressure
to increase revenue whilst ensuring compliance in each target
market. Communication, information and understanding are
the keys to success.
Reaching and engaging an increasingly sophisticated audience
worldwide is a crucial challenge. Accuracy and timeliness are
essential when documenting clinical trials, compiling internal and
external communications and marketing collateral. The challenge
of producing these materials is greatly increased when it is
necessary to create them in multiple languages. |
